Quick Links: Skip to main page content Skip to Search Skip to Topics Menu Skip to Section Content Menu Skip to Common Links
  • Decrease font size
  • Return font size to normal
  • Increase font size
U.S. Department of Health and Human Services

Vaccines, Blood & Biologics

  • Print
  • Share
  • E-mail

Section Contents Menu

  • Vaccines

    • -

    MenHibrix

    STN: BL 125363/0
    Proper Name: Meningococcal Groups C and Y and Haemophilus b Tetanus Toxoid Conjugate Vaccine
    Trade Name: MenHibrix
    Manufacturer: GlaxoSmithKline Biologicals
    Indication:

    • Indicated for active immunization to prevent invasive disease caused by Neisseria meningitidis serogroups C and Y and Haemophilus influenzae type b for children 6 weeks of age through 18 months of age.
    -
    -
    -

    Supporting Documents

    -
    -
    -
     

    Contact FDA

    (800) 835-4709
    (301) 827-1800
    Consumer Affairs Branch (CBER)

    Division of Communication and Consumer Affairs

    Office of Communication, Outreach and Development

    Food and Drug Administration

    1401 Rockville Pike

    Suite 200N/HFM-47

    Rockville, MD 20852-1448
    -
    -